Johnson, N.,
Maguire, S.,
Morra, A.,
Kapoor, P.M.,
Tomczyk, K.,
Jones, M.E.,
Schoemaker, M.J.,
Gilham, C.,
Bolla, M.K.,
Wang, Q.,
Bermisheva, M. (2021) , with additional analysis of progesterone levels in 298 premenopausal women. To
test for the association
reserpine
test. Materials and methods: N-199/1 (2 mg/kg and 4.86 mg/kg) and the reference drugs (imipramine
Guan, XX,
Zhang, YW,
Gareev, I,
Beylerli, O,
Li, XY,
Lu, GT,
Lv, L,
Hai, X (2021) treatment of the disease. This study aimed to
test our hypothesis that a miR-499a played an important role
control. Cell Counting Kit-8 assay was performed to
test the effect of EnDuo on cell viability. A scratch
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) targeting JNK. In the present study, we have
tested the hypothesis that C66 could prevent obesity
Dorling, L.,
Carvalho, S.,
Allen, J.,
González-Neira, A.,
Luccarini, C.,
Wahlström, C.,
Pooley, K.A.,
Parsons, M.T.,
Fortuno, C.,
Wang, Q.,
Bolla, M.K.,
Dennis, J.,
Bermisheva, M.,
Khusnutdinova, E.,
Prokofyeva, D.,
other additional authors (2021) BACKGROUND Genetic
testing for breast cancer susceptibility is widely used, but for many genes
Boykо, A.,
Fernández, O.,
Alifirova, V.,
Babicheva, N.,
Bakhtiyarova, K.,
Volkov, A.,
Glavinskaya, N.,
Goncharova, Z.,
Greshnova, I.,
Smagina, I.,
Lashch, N.,
Inzhinova, A. (2021) the Russian Federation would have
tested for antibodies to disorders of the optical spectrum of neuromyelitis
Boyko, A.N.,
Bakhtiyarova, K.Z.,
Brylev, L.V.,
Zakharova, M.N.,
Kasatkin, D.S.,
Korobko, D.S.,
Kotov, S.V.,
Krasnov, V.S.,
Malkova, N.A.,
Popova, E.V.,
Sivertseva, S.A.,
Simaniv, T.O.,
Sokolova, A.A.,
Totolyan, N.A.,
Trushnikova, T.N.,
Khabirov, F.A.,
Khachanova, N.V. (2021) diagnostic program including the aquaporin-4 antibodies (AQP4-IgG)
testing; to evaluate the implementation